HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Risk Factors for Haemorrhage during Suction Curettage after Uterine Artery Embolization for Treating Caesarean Scar Pregnancy: A Case-Control Study.

AbstractAIMS:
To investigate the potential risk factors for haemorrhage during suction curettage after uterine artery embolization (UAE) in the treatment of caesarean scar pregnancy (CSP).
METHODS:
A case-control study was executed including 35 patients with CSP and haemorrhage during suction curettage after UAE and 140 controls without haemorrhage. The data collected included gestational age, the distance between the gestational mass and the bladder, and the volume of vaginal bleeding.
RESULTS:
Six patients with UAE needed blood transfusions and two had a hysterectomy, while no patient in the control group needed these interventions. Multivariate analysis showed that both gestational age and the distance between the gestational mass and the bladder were associated with haemorrhage in the CSP group. The odds ratio (OR) of gestational age between cases and controls was 1.579 (95% confidence interval [CI] 1.291-1.933), and the OR of the distance between the gestational mass and the bladder was 0.208 (95% CI 0.082-0.531).
CONCLUSION:
Increased gestational age might be an important risk factor for haemorrhage during suction curettage after UAE in the treatment of patients with CSP, and a distance of >0.2 cm between the gestational mass and the bladder was protective against haemorrhage.
AuthorsYong Jiang Du, Xiao Hui Zhang, Li Quan Wang
JournalGynecologic and obstetric investigation (Gynecol Obstet Invest) Vol. 80 Issue 4 Pg. 259-64 ( 2015) ISSN: 1423-002X [Electronic] Switzerland
PMID25926054 (Publication Type: Journal Article)
Copyright© 2015 S. Karger AG, Basel.
Topics
  • Adult
  • Blood Loss, Surgical
  • Case-Control Studies
  • Cesarean Section (adverse effects)
  • Cicatrix (complications)
  • Curettage (adverse effects)
  • Female
  • Humans
  • Pregnancy
  • Pregnancy Complications (surgery)
  • Risk Factors
  • Suction (adverse effects)
  • Uterine Artery Embolization (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: